Papaverine hydrochloride

This classification denotes a vasodilating agent and phosphodiesterase inhibitor with the molecular formula C20H21NO4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 23473EC6BQ, chemically known as 6,7,3,4-tetramethoxy-1-benzylisoquinoline hydrochloride but more generally known as papaverine hydrochloride, which bears US NIH Compound Identifier 4680. European Medicines Agency schedules Papaverine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14763MIG. Most nations, for tariff and trade purposes, schedule papaverine hydrochloride under HS 29391900. As of Q4 2014, PAPAVERINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Papaverine hydrochloride bears US NLM identifiers UMLS ID C0700461 and NCI Concept Code C80006. SMILES: COC1CCC(CC1OC)CC2C3CC(C(CC3CCN2)OC)OC.CL.